Wu et al, Uroplakin II is expressed in transitional cell carc., Cancer Research 58(6) 1291-7, 1998.* |
Ogawa et al, Analysis of different. assoc. proteins in rat bladder Carcinogenesis 17 (5) 961-5, 1996.* |
Meyer-Puttlitz et al, Ectopic expression of bact lacZ gene in limbic sys. NeuroReport 6 (12) 1674-8, 1995.* |
Cordon-Cardom C. et al. “P53 Mutations In Human Bladder Cancer: Genotypic Versus Phenotypic Patterns”, 1994. Int. J. Cancer 56:347-353. |
Landis, R.J. et al., “Average Partial Association in Three-way Contingency Tables: a Review and Discussion of Alternative Tests”, 1978 Int. Stat. Rev. 46:237-254. |
Lin, J.H. et al. “Precursor Sequence, Processing, and Urothelium-specific Expression of a Major 15-kDa Protein Subunit of Asymmetric Unit Membrane”, 1994, J. Biol. Chem. 269:1775-1784. |
Metha, C.R. and Patel, N.R., “A Networth Algorithm for Performing Fisher's Exact Test in r x c Contingency Tables”, 1983, J. Am. Stat. Assoc. 78:427-434. |
Moll, et al., “Uroplakin III, ein spezifisches Membranprotein von urothelialen Deckzellen, als histologischer Market fur metastatische Urothelkarzinome”, 1993. Verh. Deutsc. Ges. Path. 77. |
Moll, R. et al., “Uroplakins, Specific Membrane Proteins of Urothelial Umbrella Cells, as Histological Markers of Metastatic Transitional Cell Carcinomas”, 1995. Am. J. Pathol. 147:1383-1397. |
Orita, M. et al., Rapid and Sensitive Detection of Point Mutations and DNA Polymorphisms Using the Polymerase Chain Reaction, 1989. Genomics 5:874-879. |
Osman, I. et al., Alterations Affecting the p53 Control Pathway in Bilharzial-related Bladder Cancer 1 1997. Clin. Can. Res. 3:531-536. |
Ryan et al., “Chromosomal localization of uroplakin genes of cattle and mice”, 1993. Mammalian Genome 4:656-661. |
Sanger, F. et al., “DNA sequencing with chain-terminating inhibitors”, 1977. Proc. Natl Acad. Sci. USA 74:5463-5467.* |
Stokke, T. et al., A Physical Map of Chromosome 20 Established Using Fluorescence in Situ Hybridization and Digital Image Analysis, 1995 Genomics 26:134-7.* |
Summerhayes et al., Monoclonal Antibodies Raised Against Cell Membrane Components of Human Bladder Tumor Tissue Recognizing Subpopulations in Normal Urothelium, 1985. JNCI 75:1025-1038.* |
Wu et al., “Large Scale Purification and Immunolocalization of Bovine Uroplakins I, II, and III”, 1990, J. Biol. Chem. 265:19170-19179.* |
Wu et al., “Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein”, 1993. J. Cell. Sci. 106:31-43.* |
Wu et al., “Mammalian Uroplakins”, 1994, J. Biol. Chem. 269:13716-13724.* |
Wu, X.R. et al., “Selective Interactions of UPIa and UPIb, Two Members of the Transmembrane 4 Superfamily, with Distinct Single Transmembrane-domained Proteins in Differentiated Urothelial Cells” 1995. J. Biol. Chem. 270:29752-29759.* |
Yu et al., “Uroplakin I: A 27-kD Protein Associated with the Asymmetric Unit Membrane of Mammalian Urothelium”, 1990, J. Cell Biol. 111:1207-1216.* |
Yu et al., “Identification of an 85-100 kDa Glycoprotein as a Cell Surface Marker for an Advanced Stage of Urothelial Differentiation: Association with the Inter-plaque (‘Hinge’) Area”, 1992. Epith. Cell Biol. 1:4-12.* |
Yu et al., “Uroplakins Ia and Ib, Two Major Differentiation Products of Bladder Epithelium, Belong to a Family of Four Transmembrane Domain (4TM) Proteins” 1994. J. Cell Biol. 125:171-182. |